Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia

Cancer

Volumn 94, Issue 9, 2002, Pages 2466-2473

  Lehtinen, Satu S ^a,b   Huuskonen, Usko E ^a   Harila Saari, Arja H ^a   Tolonen, Uolevi ^a   Vainionpää, Leena K ^a   Lanning, B Marjatta ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Acute lymphoblastic leukemia (ALL); Central nervous system (CNS); Motor evoked potentials (MEP); Neurotoxicity; Peripheral nerve

Indexed keywords

ASPARAGINASE; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; HYDROXYUREA; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; TENIPOSIDE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; HUMAN; LONG TERM CARE; LUMBAR VERTEBRA; MOTOR DYSFUNCTION; MOTOR NERVE; NEUROLOGIC DISEASE; NEUROTOXICITY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; TENDON REFLEX;

ADOLESCENT; ADULT; ARM; CHILD; EVOKED POTENTIALS, MOTOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEG; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MOTOR NEURON DISEASE; TIME FACTORS;

EID: 0036569519     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10503     Document Type: Article

References (29)

1. Neurotoxicity due to central nervous system therapy for childhood leukemia
2. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: Correlation with neuropsychologic deficiencies
3. White matter changes in children treated for acute lymphoblastic leukemia
4. Excessive spinal cord toxicity from intensive central nervous system-directed therapies
5. Vincristine neuropathy. Clinical and electrophysiological observations
6. Nerve lesions after therapy for childhood acute lymphoblastic leukemia
7. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients
8. Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve
9. Fine motor and handwriting problems after treatment for childhood acute lymphoblastic leukemia
10. Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment
11. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: A study with motor evoked potentials
12. A population-based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Incidence, patient characteristics and treatment results
13. A population-based study of children with standard risk acute lymphoblastic leukemia in the five Nordic countries. A follow-up of 230 patients
14. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)
15. Cervical magnetic stimulation in children and adolescents: Normal values and evaluation of the proximal lesion of the peripheral motor nerve in cases with polyradiculoneuropathy
16. The diagnostic value of motor evoked potentials
17. Neurotoxicology of vincristine in the cat. Morphological study
18. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials
19. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate
20. Leukoencephalopathy after chemotherapy and/or radiotherapy
21. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: Correlation with neuropsychological findings
22. Abnormal visual-evoked potentials in leukemic children after cranial radiation
23. Some aspects of neurotoxicity associated with central nervous system prophylaxis in childhood leukemia
24. Magnetic resonance imaging and magnetic resonance angiography in long term survivors of acute lymphoblastic leukemia treated with cranial irradiation
25. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity on long-term survivors of childhood leukemia given cranial radiation or parental methotrexate: A prospective study
26. Chemotherapy for acute lymphocytic leukemia: Cognitive and academic sequelae
27. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: A prospective study
28. Variability in the amplitude of skeletal muscle responses to magnetic stimulation of the motor cortex in man